2026年10月11日時点の役職
David A. Ricks
Chair and CEO, Eli Lilly and Company
最新の引用
Today, fewer than one in ten people who could benefit from a GLP-1 are taking one, held back by access, stigma, perceived complexity or the belief that their condition isn't serious enough for treatment,
公の発言を一字一句そのまま引用し、発言の場所へリンクしています。訂正や削除は「問題を報告」から。